The stock of iShares S&P TSX Capped Cmpst Indx Fnd (TSE:XIC) is a huge mover today! About 18,194 shares traded hands. iShares S&P TSX Capped Cmpst Indx Fnd (TSE:XIC) has risen 8.76% since April 8, 2016 and is uptrending. It has outperformed by 3.78% the S&P500.
The move comes after 9 months positive chart setup for the $2.56B company. It was reported on Nov, 14 by Barchart.com. We have $29.52 PT which if reached, will make TSE:XIC worth $716.80 million more.
More notable recent iShares S&P TSX Capped Cmpst Indx Fnd (TSE:XIC) news were published by: Fool.ca which released: “Here’s How to Invest in the S&P/TSX Composite â€” And Why You May Not Want To” on July 24, 2013, also Fool.ca with their article: “Play This ETF Trifecta for Long-Term Success” published on May 20, 2016, Fool.ca published: “Canadians: Ditch Your Mutual Funds and Your Mutual Fund Stocks” on September 08, 2015. More interesting news about iShares S&P TSX Capped Cmpst Indx Fnd (TSE:XIC) were released by: Theglobeandmail.com and their article: “Scouring for ETFs that mix growth, value” published on October 17, 2013 as well as Theglobeandmail.com‘s news article titled: “Monthly-pay dividend ETFs: Are you overexposed?” with publication date: April 18, 2013.
iShares S&P/TSX Capped Composite Index Fund, formerly iShares CDN S&P/TSX Capped Composite Index Fund, seeks to provide long-term capital growth by replicating, to the extent possible, the performance of the S&P/TSX Capped Composite Index through investments in the constituent issuers of such Index. The company has a market cap of $2.56 billion. The Index consists of a selection of the largest (by market capitalization) and most liquid securities listed on the Toronto Stock Exchange (TSX), selected by Standard & Poor’s (S&P) using its industrial classifications and guidelines for evaluating issuer capitalization, liquidity and fundamentals. It currently has negative earnings.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.